Parkwood »

Abcellera Biologics shares owned by Parkwood

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Parkwood from 13F filings

Historical chart of Parkwood investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Parkwood consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Parkwood

Quarter filed Position value Share count Share price at filing
2024-03-31 $98k 22k 4.55

More positions owned by Parkwood

Vanguard Total Stock Mkt Etf Etp (VTI)
Ishares Russell 2000 Etf Etp (IWM)
Spdr S&p 500 Etf Trust Etp Put Option (SPY)
Spdr Bloomberg 1-3 Month T-b Etp (BIL)
Ishares 20 Year Treasury Bo Etp Call Option (TLT)
Novo-nordisk A/s-spons Adr (NVO)
Meta Platforms Inc-class A Common Stock (META)
Elevance Health Common Stock (ELV)
Nvidia Corp Common Stock (NVDA)
Vanguard Tot World Stk Etf Etp (VT)
Uber Technologies Common Stock (UBER)
Microsoft Corp Common Stock (MSFT)
Canadian Natural Resources Common Stock (CNQ)
Visa Inc-class A Shares Common Stock (V)
Advanced Micro Devices Common Stock (AMD)

View all positions for Parkwood

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Baillie Gifford & Co
Ing Investment Management
Capital World Investors
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
Founders Fund VII Management
Federated Investors
Casdin Capital
Lazard Asset Management
Prosight Management
Guardian Capital Advisors
Two Sigma Advisers

View all funds holding Abcellera Biologics